This July, 2025, Orient Medical Solutions Co., Ltd. (OMS) has officially become the authorized distributor of Shenzhen Salus BioMed Co., Ltd. (Salus BioMed) in Vietnam, marking a significant milestone in advancing next-generation sequencing (NGS) technologies in Vietnam.
In the context of next-generation sequencing (NGS) technology gaining increasing attention and application in Vietnam, the partnership between OMS and Salus BioMed marks an important milestone in bringing advanced sequencing platforms to the market. With leading technologies such as NGS using SBS (Sequencing-by-Synthesis) and High-resolution spatial transcriptomics solutions (STS), OMS is committed to working alongside Salus to expand access to NGS, promote scientific research, and enhance the quality of diagnostics in Vietnam.
Salus BioMed: Advancing Genetic Sequencing Innovation
Salus BioMed specializes in developing high-throughput genetic sequencing platforms and is a world leader in super-resolution spatial omics research platforms, serving both research and clinical applications. With a proven track record and over 100 clients worldwide, Salus BioMed is dedicated to providing a range of cut ting-edge instruments and solutions to the sequencing and life sciences industry. This empowers users across various industry and academic research applications. Salus BioMed advanced sequencing platforms include:
1. NGS (Next-Generation Sequencing) using SBS (Sequencing-By-Synthesis): Platforms integrate proprietary technical advancements including larger optical systems, rapid biochemistry, and high-density chip design. They are engineered to meet the diverse sequencing needs across industry and academic fields, empowering scientists to explore the secret of genomes and unlock new possibilities in life.
2. High-resolution spatial transcriptomics solutions (STS): By leveraging high-throughput sequencing and super-resolution fluorescence imaging technologies, research can be more effective at a subcellular resolution analysis on tissue cell functions, intercellular microenvironment interactions, and disease pathology, etc.
Strategic Partnership for Innovation in Vietnam
The partnership between OMS and Salus Biomed represents a long-term commitment to bringing world-class genomic technologies closer to Vietnam’s healthcare and research sectors. By combining Salus’s cutting-edge sequencing solutions with OMS’s strong expertise and nationwide network, this collaboration is set to accelerate the adoption of NGS technologies and foster a more innovative biomedical ecosystem in Vietnam.
This strategic partnership not only underscores the trust between OMS and Salus BioMed but also reflects a shared vision: to empower Vietnamese scientists and healthcare providers with the tools needed to drive innovation, improve patient outcomes, and contribute to the future of global genomics.
————
About Orient Medical Solutions Co., Ltd. (OMS)
We provide one-stop advisory and distribution services for medical and life science manufacturers looking to enter and succeed in Vietnam’s dynamic healthcare sector. With deep expertise across international markets—including China, Vietnam, Australia and other Southeast Asia countries—we turn market entry challenges into growth opportunities.
Address: Commercial service apartment No. 1.02, Block B, 1st and 2nd floor – Eastmark City Apartment, No. 39A, Street No. 149C, Long Truong Ward, Ho Chi Minh City
Website: https://orientmedvn.com/
Email: [email protected]